Resolve M TherapeuticsListed
No domain yetbiotech_life_sciences
Biotechnology company developing a discovery platform to engage the immune system’s pro-resolution responses and restore immune balance in chronic inflammatory and autoimmune diso…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Biotechnology company developing a discovery platform to engage the immune system’s pro-resolution responses and restore immune balance in chronic inflammatory and autoimmune diso…
Distalmotion is a Swiss MedTech company developing the DEXTER robotic surgery system, designed to simplify minimally invasive laparoscopic procedures and expand access to robotic…
HistoSonics is a medical device company developing non-invasive histotripsy technology for tumor treatment, specifically targeting liver tumors using focused ultrasound.
Ronovo Surgical focuses on addressing unmet clinical needs in surgery through the application of robotic and digital technologies. They developed the Carina™ Platform, which inclu…
Aliada Therapeutics is a neuroscience-focused company working towards overcoming the delivery hurdle in large molecule drug development. Aliada is advancing a generation of CNS th…
Clinical-stage biopharmaceutical company developing first-in-class therapeutics to protect retinal cells and preserve vision in retinal diseases. Its lead candidate, xelafaslatide…
Clinical-stage ophthalmic medical device company developing Quantitative Corneal Cross-Linking (qCXL™), a personalized, non-invasive approach to refractive vision correction. Its…
Flindr is building a pipeline of first-in-class small molecule inhibitors for the precision treatment of cancer using its ImmunoGram Drug Discovery Engine.
Accent is leading the translation of RNA-modifying protein (RMP) biology into promising new therapies by combining a robust chemical biology platform with rigorous approaches to t…
Citryll is a biotech company developing innovative therapies for immune-mediated inflammatory diseases by targeting Extracellular Traps. It raised EUR 85 million in Series B fundi…
Seoul-based biotechnology company developing orally available, brain-penetrating small-molecule therapeutics using its proprietary SPiDEM targeted protein degradation platform. It…